Avison Young has reported that there has been a decline in venture capital funding for life sciences in the Bay Area, resulting in a rise in vacancies in the sector. In the fourth quarter of 2023, VC funding barely surpassed $500 million, compared to the boom in funding seen from 2020 to mid-2022, when quarterly funding regularly exceeded $2 billion. Avison Young suggests that the decrease in funding is due to the waning allure of biopharmaceutical investments and the increasing focus on the AI industry. As a result, more life science companies are choosing to sublease their spaces, leading to a steady increase in vacancies since 2022. With over seven million square feet of life science space currently under construction, the market is likely to face a vacancy issue in the coming years.
Surging Job Opportunities in Bay Area’s Thriving Life Science
Latest from Blog
VCFA Group Closes $1225M Venture Partners VII Fund
TLDR: VCFA Group closed VCFA Venture Partners VII fund with $122.5 million in commitments Transition marks continuation of VCFA’s pioneering legacy in the secondary private equity space VCFA Group, a pioneer in
VCFA Group’s Venture Partners VII Fund Raises $1225 Million
TLDR: VCFA Group closed its latest fund, VCFA Venture Partners VII, with $122.5 million in commitments. The fund focuses on smaller and more complex purchases of later-stage venture capital and growth equity
Revolutionizing Payments: $20M Raised for Stablecoin Network Development
TLDR: 1Money has raised over $20 million in seed funding to develop a stablecoin payments network. The network aims to offer instant transaction confirmation, low-cost fees, multicurrency support, compliance mechanisms, and scalability.
Top AI Trends and Startups Shaping 2025 and Beyond
“`html TLDR: Israel is excelling in applicative and vertical AI, focusing on practical solutions in cybersecurity, healthcare, and defense rather than competing with tech giants in foundational AI models. Five key AI
Sand Hill Road: Steve Vassallo’s Early Investment Edge at Foundation Capital
“`html TLDR: Steve Vassallo, a general partner at Foundation Capital, focuses on early-stage investments, often being the first institutional investor for startups. He emphasizes the importance of owning a significant stake in